Abstract
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Yonatan Moshkovits, Tsahi T. Lerman, Alon Barsheshet, Shir Tal, Gregory Golovchiner, Aharon Erez
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Association between triglyceride-glucose index and atrial fibrillation: a retrospective observational study
10.3389/fendo.2022.1047927 · 2022
Epidemiology of atrial fibrillation in the 21st century: novel methods and new insights
10.1161/circresaha.120.316340 · 2020
Worldwide Epidemiology of atrial fibrillation: a global burden of disease 2010 study
10.1161/circulationaha.113.005119 · 2014
Early rhythm-control therapy in patients with atrial fibrillation
10.1056/nejmoa2019422 · 2020
Outcomes of patients with atrial fibrillation on oral anticoagulation with and without heart failure: the ETNA-AF-Europe registry
10.1093/europace/euad280 · 2023
Catheter ablation for atrial fibrillation and impact on clinical outcomes
10.1093/ehjopen/oeae058 · 2024
Time trends in patient characteristics, anticoagulation treatment, and prognosis of incident Nonvalvular atrial fibrillation in the Netherlands
10.1001/jamanetworkopen.2023.9973 · 2023
Nationwide epidemiology and management time trends for atrial fibrillation
2026
Recent time trends in incidence, outcome and premorbid treatment of atrial fibrillation-related stroke and other embolic vascular events: a population-based study
unpaywall
Confidence 95%
datacite
Confidence 0%
10.1136/jnnp-2015-311947 · 2017
Long-term outcomes after hospitalization for atrial fibrillation or flutter
10.1093/eurheartj/ehae204 · 2024
Incidence, predictors and mortality risk of new heart failure in patients hospitalised with atrial fibrillation
10.1136/heartjnl-2020-318648 · 2021
Two aspects of labor mobility: a bivariate Poisson regression approach
10.1007/bf01176203 · 1993
Temporal trends in incidence, prevalence, and mortality of atrial fibrillation in primary care
10.1161/jaha.116.005155 · 2017
Incidence and prevalence of atrial fibrillation and associated mortality among Medicare beneficiaries, 1993-2007
10.1161/circoutcomes.111.962688 · 2012
Incidence and prevalence of atrial fibrillation and associated mortality among Medicare beneficiaries: 1993–2007
10.1161/circoutcomes.111.962688 · 2012
Atrial fibrillation: a risk factor or risk marker?
10.1093/eurheartj/ehw313 · 2016
30-year nationwide trends in incidence of atrial fibrillation in Denmark and associated 5-year risk of heart failure, stroke, and death
10.1016/j.ijcard.2016.09.071 · 2016
Temporal trends in incidence, prevalence, and mortality of atrial fibrillation in primary care
10.1161/jaha.116.005155 · 2017
Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA randomized clinical trial
10.1001/jama.2019.0693 · 2019
National trends in atrial fibrillation hospitalization, readmission, and mortality for medicare beneficiaries, 1999-2013
10.1161/circulationaha.116.022388 · 2017
Apixaban versus warfarin in patients with atrial fibrillation
10.1056/nejmoa1107039 · 2011
A comparison of outcomes with apixaban, rivaroxaban, and warfarin for atrial fibrillation and/or venous thromboembolism
10.1016/j.jacadv.2025.101714 · 2025
2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
10.1093/eurheartj/ehae176 · 2024
No additional external references are available.